Physician profile
Eric T Vessels
NPI 1033351820
$2,660.74
in general payments reported to CMS, 2019-2025
21 companies · $495 in 2025
The $495 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $33.57 · 2021: $395 · 2022: $106 · 2023: $392 · 2024: $1,101 · 2025: $495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,582 · Travel and Lodging: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,582.36 |
| Travel and Lodging | $404.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $1,059.65 | 2019-2025 | |
| Abbvie INC. | $421.63 | 2021-2025 | Botox, Qulipta |
| Abbott Laboratories | $375.26 | 2019-2025 | Proclaim, Penta, Eterna |
| Lundbeck LLC | $237.95 | 2021-2024 | Vyepti |
| Revance Therapeutics, INC. | $90.64 | 2024 | Daxxify |
| Lilly USA, LLC | $49.79 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.83 | 2025 | Relistor |
| Stryker Corporation | $43.21 | 2025 | Augment Injectable |
| Biohaven Pharmaceuticals, INC. | $41.60 | 2021 | |
| Novartis Pharmaceuticals Corporation | $35.36 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $35.10 | 2025 | Zilretta |
| Amgen INC. | $34.00 | 2022 | |
| Daiichi Sankyo INC. | $33.57 | 2019 | |
| Collegium Pharmaceutical, INC. | $26.11 | 2019-2021 | |
| Averitas Pharma INC. | $24.00 | 2025 | Qutenza |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $23.54 | 2021 | |
| Valinor Pharma, LLC | $22.29 | 2025 | Movantik |
| Globus Medical, INC. | $18.42 | 2025 | Senza |
| Allergan, INC. | $14.85 | 2020 | |
| Arbor Pharmaceuticals, INC. | $14.74 | 2021 | |
| Nevro Corp. | $12.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Vessels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.